secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2022-08-30T23:59:59+00:00
Accession:  0000914475-22-000050
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine to acquire Diurnal Group for £48.3M cash
---------------------------------------------------

- Acquiring entire issued share capital of Diurnal for ~£48.3M (~$56.5M) in an all-cash transaction.
- Transaction conditional on approval by Diurnal shareholders and other customary closing conditions.
- Neurocrine expects deal to accelerate establishment of UK clinical development and commercial capabilities.
- Announcement made under Rule 2.7 of the UK City Code on Takeovers and Mergers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447522000050/0000914475-22-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447522000050/nbix-20220830.htm
  HTML page:      https://secwatch.observer/filing/0000914475-22-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer